Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group

H Bell; K Hellum; S Harthug; B Myrvang; S Ritland; A Maeland; B von der Lippe; K Bjøro; K Skaug; B G Gutigard; N Raknerud; P Simmonds

doi:10.1080/00365529950173087

Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group

H Bell, K Hellum, S Harthug, B Myrvang, S Ritland, A Maeland, B von der Lippe, K Bjøro, K Skaug, B G Gutigard, N Raknerud, P Simmonds

Royal (Dick) School of Veterinary Studies

Research output: Contribution to journal › Article › peer-review

Abstract

Preliminary results from combination therapy with interferon-alpha and ribavirin (IFN/Rib) in patients with chronic hepatitis C have been promising, with up to 50% sustained hepatitis C virus (HCV) RNA response. The aim of this study was to investigate whether a sustained HCV RNA response could be obtained with combination therapy in patients who were non-responders or relapsers after IFN treatment.

Original language	English
Pages (from-to)	194-8
Number of pages	5
Journal	Scandinavian Journal of Gastroenterology
Volume	34
Issue number	2
DOIs	https://doi.org/10.1080/00365529950173087
Publication status	Published - Feb 1999

Keywords / Materials (for Non-textual outputs)

Adult
Antiviral Agents
Biopsy
Drug Administration Schedule
Drug Therapy, Combination
Female
Hepacivirus
Hepatitis C, Chronic
Humans
Interferon-alpha
Male
Middle Aged
RNA, Viral
Recombinant Proteins
Ribavirin
Viremia

Access to Document

10.1080/00365529950173087

Cite this

Bell, H., Hellum, K., Harthug, S., Myrvang, B., Ritland, S., Maeland, A., von der Lippe, B., Bjøro, K., Skaug, K., Gutigard, B. G., Raknerud, N., & Simmonds, P. (1999). Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group. Scandinavian Journal of Gastroenterology, 34(2), 194-8. https://doi.org/10.1080/00365529950173087

@article{b3a27b4992594d679e86c84b5e4f840a,

title = "Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group",

abstract = "Preliminary results from combination therapy with interferon-alpha and ribavirin (IFN/Rib) in patients with chronic hepatitis C have been promising, with up to 50% sustained hepatitis C virus (HCV) RNA response. The aim of this study was to investigate whether a sustained HCV RNA response could be obtained with combination therapy in patients who were non-responders or relapsers after IFN treatment.",

keywords = "Adult, Antiviral Agents, Biopsy, Drug Administration Schedule, Drug Therapy, Combination, Female, Hepacivirus, Hepatitis C, Chronic, Humans, Interferon-alpha, Male, Middle Aged, RNA, Viral, Recombinant Proteins, Ribavirin, Viremia",

author = "H Bell and K Hellum and S Harthug and B Myrvang and S Ritland and A Maeland and {von der Lippe}, B and K Bj{\o}ro and K Skaug and Gutigard, {B G} and N Raknerud and P Simmonds",

year = "1999",

month = feb,

doi = "10.1080/00365529950173087",

language = "English",

volume = "34",

pages = "194--8",

journal = "Scandinavian Journal of Gastroenterology",

issn = "0036-5521",

publisher = "Taylor & Francis",

number = "2",

}

Bell, H, Hellum, K, Harthug, S, Myrvang, B, Ritland, S, Maeland, A, von der Lippe, B, Bjøro, K, Skaug, K, Gutigard, BG, Raknerud, N & Simmonds, P 1999, 'Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group', Scandinavian Journal of Gastroenterology, vol. 34, no. 2, pp. 194-8. https://doi.org/10.1080/00365529950173087

TY - JOUR

T1 - Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group

AU - Bell, H

AU - Hellum, K

AU - Harthug, S

AU - Myrvang, B

AU - Ritland, S

AU - Maeland, A

AU - von der Lippe, B

AU - Bjøro, K

AU - Skaug, K

AU - Gutigard, B G

AU - Raknerud, N

AU - Simmonds, P

PY - 1999/2

Y1 - 1999/2

N2 - Preliminary results from combination therapy with interferon-alpha and ribavirin (IFN/Rib) in patients with chronic hepatitis C have been promising, with up to 50% sustained hepatitis C virus (HCV) RNA response. The aim of this study was to investigate whether a sustained HCV RNA response could be obtained with combination therapy in patients who were non-responders or relapsers after IFN treatment.

AB - Preliminary results from combination therapy with interferon-alpha and ribavirin (IFN/Rib) in patients with chronic hepatitis C have been promising, with up to 50% sustained hepatitis C virus (HCV) RNA response. The aim of this study was to investigate whether a sustained HCV RNA response could be obtained with combination therapy in patients who were non-responders or relapsers after IFN treatment.

KW - Adult

KW - Antiviral Agents

KW - Biopsy

KW - Drug Administration Schedule

KW - Drug Therapy, Combination

KW - Female

KW - Hepacivirus

KW - Hepatitis C, Chronic

KW - Humans

KW - Interferon-alpha

KW - Male

KW - Middle Aged

KW - RNA, Viral

KW - Recombinant Proteins

KW - Ribavirin

KW - Viremia

U2 - 10.1080/00365529950173087

DO - 10.1080/00365529950173087

M3 - Article

C2 - 10192200

SN - 0036-5521

VL - 34

SP - 194

EP - 198

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

IS - 2

ER -

Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group

Abstract

Keywords / Materials (for Non-textual outputs)

Access to Document

Fingerprint

Cite this